ARTICLE | Emerging Company Profile
Sofinnova’s Papiernik, Costa and Roche alum Garibaldi carve orphan neurology play Noema out of the pharma’s assets
Emerging Company Profile: Noema emerges from stealth with $59M to develop four clinical neurology programs in-licensed from Roche
December 2, 2020 2:08 AM UTC
Five years after Sofinnova Partners’ Antoine Papiernik first connected with Roche neurology veteran George Garibaldi, the pair have teamed up with Luigi Costa to launch orphan neurology company Noema. The trio formed the Basel-based company with seed money from Sofinnova Partners and a quartet of clinical neurology programs deprioritized by Roche.
On Tuesday, Noema Pharma AG emerged from stealth with a CHF54 million ($59.3 million) in a series A round led by Sofinnova and Polaris Partners and plans to begin three Phase II trials next half. ...
BCIQ Company Profiles